These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6312824)
1. Ketoconazole protects against infection with Trypanosoma cruzi in a murine model. McCabe RE; Araujo FG; Remington JS Am J Trop Med Hyg; 1983 Sep; 32(5):960-2. PubMed ID: 6312824 [TBL] [Abstract][Full Text] [Related]
2. Ketoconazole inhibition of intracellular multiplication of Trypanosoma cruzi and protection of mice against lethal infection with the organism. McCabe RE; Remington JS; Araujo FG J Infect Dis; 1984 Oct; 150(4):594-601. PubMed ID: 6092485 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of itraconazole against Trypanosoma cruzi. McCabe RE; Remington JS; Araujo FG Am J Trop Med Hyg; 1986 Mar; 35(2):280-4. PubMed ID: 3006529 [TBL] [Abstract][Full Text] [Related]
4. Primaquine is lethal for intracellular but not extracellular Trypanosoma cruzi. McCabe RE J Parasitol; 1988 Oct; 74(5):748-53. PubMed ID: 3138394 [TBL] [Abstract][Full Text] [Related]
5. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Urbina JA; Lazardi K; Marchan E; Visbal G; Aguirre T; Piras MM; Piras R; Maldonado RA; Payares G; de Souza W Antimicrob Agents Chemother; 1993 Mar; 37(3):580-91. PubMed ID: 8460926 [TBL] [Abstract][Full Text] [Related]
6. Ketoconazole promotes parasitological cure of mice infected with Trypanosoma cruzi. McCabe RE; Remington JS; Araujo FG Trans R Soc Trop Med Hyg; 1987; 81(4):613-5. PubMed ID: 3127963 [TBL] [Abstract][Full Text] [Related]
7. A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease. Araújo MS; Martins-Filho OA; Pereira ME; Brener Z J Antimicrob Chemother; 2000 Jun; 45(6):819-24. PubMed ID: 10837436 [TBL] [Abstract][Full Text] [Related]
8. An experimental and clinical assay with ketoconazole in the treatment of Chagas disease. Brener Z; Cançado JR; Galvão LM; da Luz ZM; Filardi Lde S; Pereira ME; Santos LM; Cançado CB Mem Inst Oswaldo Cruz; 1993; 88(1):149-53. PubMed ID: 8246750 [TBL] [Abstract][Full Text] [Related]
9. The efficacy of an N-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice. Scott VR; Matthews TR Am J Trop Med Hyg; 1987 Sep; 37(2):308-13. PubMed ID: 3116868 [TBL] [Abstract][Full Text] [Related]
10. [In vivo and in vitro susceptibility of Trypanosoma cruzi to ketoconazole]. Rubiolo ER; Cano RC Rev Latinoam Microbiol; 1987; 29(4):395-401. PubMed ID: 3149794 [No Abstract] [Full Text] [Related]
11. The activity of ketoconazole and other azoles against Trypanosoma cruzi: biochemistry and chemotherapeutic action in vitro. Goad LJ; Berens RL; Marr JJ; Beach DH; Holz GG Mol Biochem Parasitol; 1989 Jan; 32(2-3):179-89. PubMed ID: 2494453 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Urbina JA; Vivas J; Lazardi K; Molina J; Payares G; Piras MM; Piras R Chemotherapy; 1996; 42(4):294-307. PubMed ID: 8804798 [TBL] [Abstract][Full Text] [Related]
13. Infectivity of amastigotes of Trypanosoma cruzi. de Carvalho TU; de Souza W Rev Inst Med Trop Sao Paulo; 1986; 28(4):205-12. PubMed ID: 3105036 [No Abstract] [Full Text] [Related]
14. Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo. Raether W; Seidenath H Z Parasitenkd; 1984; 70(1):135-8. PubMed ID: 6320547 [No Abstract] [Full Text] [Related]
15. In pursuit of drugs for American trypanosomiasis: evaluation of some "standards" in a mouse model. Kinnamon KE; Poon BT; Hanson WL; Waits VB Proc Soc Exp Biol Med; 1997 Dec; 216(3):424-8. PubMed ID: 9402149 [TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Urbina JA; Payares G; Contreras LM; Liendo A; Sanoja C; Molina J; Piras M; Piras R; Perez N; Wincker P; Loebenberg D Antimicrob Agents Chemother; 1998 Jul; 42(7):1771-7. PubMed ID: 9661019 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activities of formycin B against Trypanosoma cruzi. McCabe RE; Remington JS; Araujo FG Antimicrob Agents Chemother; 1985 Apr; 27(4):491-4. PubMed ID: 3923921 [TBL] [Abstract][Full Text] [Related]
18. Aetiological treatment with itraconazole or ketoconazole in individuals with Trypanosoma cruzi/HIV co-infection. de Almeida EA; Silva EL; Guariento ME; Aoki FH; Pedro Rde J Ann Trop Med Parasitol; 2009 Sep; 103(6):471-6. PubMed ID: 19695152 [TBL] [Abstract][Full Text] [Related]
19. Antiprotozoal drug nitazoxanide enhances parasitemia, tissue lesions and mortality caused by Trypanosoma cruzi in murine model. Valle-Reyes JS; Melnikov V; Dobrovinskaya O; Rodriguez-Hernández A; Wookee-Zea C; Pimientel-Rodrigez V; Rueda-Valdovinos G; Delgado-Enciso I; López-Lemus UA; Espinoza-Gómez F Exp Parasitol; 2017 Jan; 172():44-50. PubMed ID: 28011170 [TBL] [Abstract][Full Text] [Related]